References
- Sasaki J, Waterman MR, Buchanan GR, Cottam GL. Plasma and erythrocyte lipids in sickle cell anaemia. Clin Lab Haematol 1983; 5: 35–44.
- El-Hazmi MAF, Jabbar FA, Warsy AS. Cholesterol and triglyceride level in patients with sickle cell anaemia. Scand J Clin Lab Invest 1987; 47: 351–4.
- Onajobi F. Serum total and low density and very low density lipoprotein cholesterol in a normal Nigerian population. Nig Med J 1982; 2: 11–14.
- Serjeant GR. The clinical features of sickle cell disease. In: Bearn AG, Black DAK, Hiatt HH, eds. Clinical Studies. Amsterdam: North-Holland, 1974; 81–2.
- Marengo-Rowe AJ. Rapid electrophoresis and quantitation of haemoglobins on cellulose acetate. J Clin Pathol 1935; 18: 790–2
- Robinson AR, Robson M, Harrison AP, Suelzer WW. A new technique for differentiation of haemoglobin. J Lab Clin Med 1957; 50: 745–52.
- DeLong DM, DeLong RE, Wood P, et al. A comparison of methods for the estimation of plasma low and very low density lipoprotein cholesterol. JAMA 1986; 256: 2372–7.
- Suha N, Samuel APW. Sickle cell gene and liver function in a Sudanese population. Acta Haematol 1982; 68: 65–7.
- Berreras L, Diggs LW, Lipscomb A. Plasma volume in sickle cell disease. South Med J 1966; 59: 456–8.
- Jenkins MHS Scott RB, Ferguson AD. Studies in sickle cell anaemia. Blood volume relationship and the use of a plasma extender in sickle cell disease in childhood: a preliminary report. Pediatrics 1956; 18: 239–447.
- Thompson PD, Cullinane EM, Sady SP. Modest changes in high density lipoprotein concentration and metabolism with prolonged exercise training. Circulation 1988; 78: 25–34.
- Steinberg D. Lipoproteins and atherosclerosis: a look back and a look ahead. Arteriosclerosis 1983; 3: 283–301.
- National Heart, Lung and Blood Institute Consensus Development Panel. Lowering blood cholesterol to prevent heart disease. JAMA 1985; 253: 2080–6.
- Brown MS, Goldstein JL. A receptor mediated pathway for cholesterol homeostasis. Science 1986; 232: 34–47.
- Castelli WP, Garrison RJ, Wilson PWF, et al. Incidence of coronary artery disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 1986; 256: 2835–8.
- Lipinska I, Gurewich V. The value of measuring per cent high density lipoprotein in assessing risk of cardiovascular disease. Arch Intern Med 1982; 142: 469–72.
- Olukoga AO, Adewoye HO, Erasmus RT, Adedoyin MA. Erythrocyte and plasma magnesium in sickle cell anaemia. East Afr Med J 1990; 5: 348–54.
- Rayssiginer Y. Magnesium, lipids and vascular diseases. Experimental evidence in animal models. Magnesium 1986; 5: 182–90.